Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Diffusion Pharmaceuticals Inc. (DFFN)
NASDAQ:DFFN
Holding DFFN?
Track your performance easily
DFFN Stock Chart & Stats
Day’s Range$6.25 - $7.79
52-Week Range― - ―
Previous Close$5.91
Volume351.06K
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 13, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Diffusion Pharmaceuticals News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DFFN FAQ
What was Diffusion Pharmaceuticals Inc.’s price range in the past 12 months?
Currently, no data Available
What is Diffusion Pharmaceuticals Inc.’s market cap?
Currently, no data Available
When is Diffusion Pharmaceuticals Inc.’s upcoming earnings report date?
Diffusion Pharmaceuticals Inc.’s upcoming earnings report date is Nov 13, 2023 which is 367 days ago.
How were Diffusion Pharmaceuticals Inc.’s earnings last quarter?
Diffusion Pharmaceuticals Inc. released its earnings results on Aug 14, 2023. The company reported -$1.554 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.554.
Is Diffusion Pharmaceuticals Inc. overvalued?
According to Wall Street analysts Diffusion Pharmaceuticals Inc.’s price is currently Overvalued.
Does Diffusion Pharmaceuticals Inc. pay dividends?
Diffusion Pharmaceuticals Inc. does not currently pay dividends.
What is Diffusion Pharmaceuticals Inc.’s EPS estimate?
Diffusion Pharmaceuticals Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Diffusion Pharmaceuticals Inc. have?
Currently, no data Available
What happened to Diffusion Pharmaceuticals Inc.’s price movement after its last earnings report?
Diffusion Pharmaceuticals Inc. reported an EPS of -$1.554 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.385%.
Which hedge fund is a major shareholder of Diffusion Pharmaceuticals Inc.?
Currently, no hedge funds are holding shares in DFFN
---
Diffusion Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Diffusion Pharmaceuticals Inc.
Diffusion Pharmaceuticals, Inc. is a clinical stage company which engages lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate, for use in those life threatening conditions in which cellular oxygen deprivation is the basis for significant unmet medical needs. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.
---
DFFN Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---